How can we improve the pre-clinical development of drugs for stroke?
Top Cited Papers
- 1 September 2007
- journal article
- review article
- Published by Elsevier in Trends in Neurosciences
- Vol. 30 (9) , 433-439
- https://doi.org/10.1016/j.tins.2007.06.009
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Systematic Review and Meta-Analysis of the Efficacy of Tirilazad in Experimental StrokeStroke, 2007
- Translating animal research into clinical benefitBMJ, 2007
- Comparison of treatment effects between animal experiments and clinical trials: systematic reviewBMJ, 2006
- 1,026 Experimental treatments in acute strokeAnnals of Neurology, 2006
- Nimodipine in Animal Model Experiments of Focal Cerebral IschemiaStroke, 2001
- Calcium Antagonists for Ischemic StrokeStroke, 2001
- Tirilazad Mesylate in Acute Ischemic StrokeStroke, 2000
- Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug DevelopmentStroke, 1999
- Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsJAMA, 1995
- The file drawer problem and tolerance for null results.Psychological Bulletin, 1979